SCHEMBL7960191

SCHEMBL7960191

Fc1ccc(N2CCN(CCCc3onc4c3COCC4)CC2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 8/20 0.43
DRD3 P35462 8/20 0.43
HTR1A P08908 8/20 0.43
HTR2A P28223 6/20 0.43
DRD4 P21917 4/20 0.43
DRD1 P21728 4/20 0.43
TMEM97 Q5BJF2 3/20 0.43
SIGMAR1 Q99720 3/20 0.43
DRD5 P21918 3/20 0.43
TLR9 Q9NR96 1/20 0.41
ADRA2A P08913 1/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
ADRA1D P25100 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
HTR2B P41595 1/20 0.41
HRH1 P35367 2/20 0.40
HTR2C P28335 1/20 0.40
PARP1 P09874 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7949134 0.89 SIGMAR1 (0.48) DRD2DRD3HTR1AHTR2ADRD4
SCHEMBL7949605 0.86 DRD2 (0.48) DRD2DRD3HTR1AHTR2ADRD4
SCHEMBL7959798 0.85 DRD2 (0.47) DRD2DRD3HTR1AHTR2ADRD4
SCHEMBL5772376 0.81 HTR1A (0.43) DRD2DRD3HTR1AHTR2ADRD4
Hydrochloric Acid SCHEMBL7959877 0.81 DRD3 (0.51) DRD2DRD3HTR1AHTR2ADRD4
SCHEMBL7965107 0.75 SIGMAR1 (0.51) DRD2DRD3HTR1AHTR2ADRD4
SCHEMBL7963959 0.75 MAPT (0.44) SIGMAR1ADRA1DADRA1AADRA1BHRH1
SCHEMBL7963539 0.74 SIGMAR1 (0.50) DRD2DRD3HTR1AHTR2ADRD4
Hydrochloric Acid SCHEMBL7960917 0.73 SIGMAR1 (0.49) DRD2DRD3HTR1AHTR2ADRD4
SCHEMBL7959558 0.72 SIGMAR1 (0.47) DRD2DRD3HTR1AHTR2ADRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed